Actively hiring
As featured in
Claim pageClaim
Follow
Overview
News
Technologies
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Team
51-200
employees, estimated range
Hiring now
4
open roles
Backers
2
Atinum Investment, LB Investment
Momentum
15/100
in the news
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Apr 13
Board appointment Orum Therapeutics Appoints Dr. Maria Koehler and Geoff Meyerson to Board of Directors · morningstar.com
Jan 4
New executive Orum Therapeutics Appoints Chad May as Chief Scientific Officer to Drive Degrader-Antibody Conjugate Innovation and Programs · businesswire.com
Oct 14, 2025
New executive Orum Therapeutics Appoints Dr. Dorin Toader as Head of Platform Technology to Advance Orum's Degrader-Antibody Conjugate Payload Platforms and Expand… · streetinsider.com
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers

immunitoAI is an AI-driven biotechnology company accelerating antibody discovery and the development of antibody-based therapies through…

Magnet Biomedicine is advancing monovalent molecular glue inhibitors (MGIs) and innovative protein degraders to engage disease drivers.

PROTEINA is a South Korean biotechnology company that uses its own SPID single-molecule protein-protein interaction detection technology to…

We engineer neomorphic protein surfaces to unlock targeted protein degradation.

Hone Bio develops NanoPilot, a dual-targeting technology that enables cell-specific LNP delivery whilst actively blocking off-target…

Degrading proteins.Saving lives.. Biotheryx is advancing a portfolio of first-in-class protein degraders, with an initial focus on…
How Orum Therapeutics hires
Truth index
B 75/100
Ghost roles
0%
Stale roles
100%
Reposted roles
0%
Orum Therapeutics scores B on the Alion truth index (A is best, E worst), measured over 3 open roles re-checked against its own hiring board: 0% look like ghost listings, 100% have gone stale and 0% are the same role posted again. It measures how much of what this employer publishes turns into a real, finite search - not the employer as a workplace. How the index is computed
News
Orum Therapeutics wins FDA nod to start phase 1 trial for AML drug
Orum Therapeutics wins FDA nod to start phase 1 trial for AML drug IND greenlight paves way for first-in-human test of dac therapy orm-1153 in relapse
Read more
Report
Report
Orum Therapeutics to Present New Preclinical Data on ORM-1153, a CD123-Targeting Degrader Antibody Conjugate, at the AACR Annual Meeting 2026
Read more
Report
Orum Therapeutics Names Chad May As Chief Scientific Officer
Orum Therapeutics, a biotechnology company developing degrader-antibody conjugates (DACs), has appointed Chad May, Ph.D., as Chief Scientific Officer, bringing more than two decades of oncology and immunology R&D experience spanning antibody-drug conjugat
Read more
Report
Orum Therapeutics Appoints Chad May as Chief Scientific Officer to Drive Degrader-Antibody Conjugate Innovation and Programs
Read more
Report
Orum Therapeutics Secures Approximately US$100 Million to Accelerate Development of Leading Degrader Antibody Conjugate Programs to Treat Serious Diseases
Read more
Report
Orum Therapeutics Announces Presentation of Preclinical Data for ORM-1153 at the 2025 American Society of Hematology (ASH) Annual Meeting
BOSTON & DAEJEON, South Korea, November 03, 2025--Orum Therapeutics Announces Presentation of Preclinical Data for ORM-1153 at the 2025 American Society of Hematology (ASH) Annual Meeting
Read more
Report
Orum Therapeutics Appoints Dr. Dorin Toader as Head of Platform Technology to Advance Orum's Degrader-Antibody Conjugate Payload Platforms and Expand TPD² Therapeutic ...
Read more
Report
Raleigh, NC Breaking News, Weather, Traffic - WRAL NBC affiliate
Get the latest Raleigh area news, weather forecasts, I-40 traffic, ACC and high school sports, strange news and blogs for Central and Eastern North Carolina, including Raleigh, Durham, Cary, Chapel Hill, Fayetteville, Rocky Mount and Wilson.
Read more
Report
Tech stack
Technologies named in job postings at Orum Therapeutics over the last 12 months, by layer, with the share of postings for each.
Technologies in use
1
Postings analysed
1
Stack modernity
64/100
Cloud & platforms
GCP
Sign in to see how your skills match this stack
Sign In
Growth
Hiring Momentum
23/100
Hiring freeze
Open positions
4
0 opened / 0 closed in 30 days
Median time-to-fill
63 days
faster than 21% of the market
ATS activity
Every ~4 hours
Today
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Finance
50% ▼
Management
50% ▼
Offices
Where the company hires and what each office is for
Cities
2
Hiring now
2
Countries
2
Busiest office
Lexington
Loading the map
Headquarters
Builds here
Office with open vacancies
Tap a pin for the office
Lexington
United States
2 open roles 1 posted in 90 days 100% engineering 50-200 est. staff
hires for Science & Research
Daejeon
South Korea
2 open roles 1 posted in 90 days 10-50 est. staff
hires for Finance, Legal

Atinum Investment
LB Investment 



